OPNT Annual Accounts Payable
$3.37 M
+$403.30 K+13.60%
31 December 2021
Summary:
As of February 5, 2025, OPNT annual accounts payable is $3.37 million, with the most recent change of +$403.30 thousand (+13.60%) on December 31, 2021. During the last 3 years, it has risen by +$2.24 million (+197.42%).OPNT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Quarterly Accounts Payable
$3.11 M
+$11.70 K+0.38%
30 September 2022
Summary:
As of February 5, 2025, OPNT quarterly accounts payable is $3.11 million, with the most recent change of +$11.70 thousand (+0.38%) on September 30, 2022. Over the past year, it has increased by +$532.20 thousand (+20.62%).OPNT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OPNT Accounts Payable Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +13.6% | +20.6% |
3 y3 years | +197.4% | +59.5% |
5 y5 years | +6.7% | +146.1% |
OPNT Accounts Payable High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | ||||
5 y | 5-year | ||||
alltime | all time | at high | -41.5% |
Opiant Pharmaceuticals Accounts Payable History
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $3.11 M(+0.4%) |
June 2022 | - | $3.10 M(-41.7%) |
Mar 2022 | - | $5.32 M(+57.8%) |
Dec 2021 | $3.37 M(+13.6%) | $3.37 M(+30.6%) |
Sept 2021 | - | $2.58 M(+5.5%) |
June 2021 | - | $2.45 M(-33.5%) |
Mar 2021 | - | $3.68 M(+24.1%) |
Dec 2020 | $2.97 M(+125.3%) | $2.97 M(+16.2%) |
Sept 2020 | - | $2.55 M(+79.8%) |
June 2020 | - | $1.42 M(-2.1%) |
Mar 2020 | - | $1.45 M(+10.2%) |
Dec 2019 | $1.32 M(+16.2%) | $1.32 M(-32.5%) |
Sept 2019 | - | $1.95 M(+81.8%) |
June 2019 | - | $1.07 M(-27.5%) |
Mar 2019 | - | $1.48 M(+30.8%) |
Dec 2018 | $1.13 M(-64.1%) | $1.13 M(-14.0%) |
Sept 2018 | - | $1.32 M(-40.0%) |
June 2018 | - | $2.19 M(-37.9%) |
Mar 2018 | - | $3.54 M(+179.4%) |
Dec 2017 | $3.16 M(+42.7%) | - |
Oct 2017 | - | $1.26 M(-42.8%) |
July 2017 | $2.21 M(+1473.3%) | $2.21 M(+59.0%) |
Apr 2017 | - | $1.39 M(+83.9%) |
Jan 2017 | - | $756.20 K(+17.9%) |
Oct 2016 | - | $641.50 K(+356.3%) |
July 2016 | $140.60 K | $140.60 K(-32.0%) |
Apr 2016 | - | $206.80 K(+487.5%) |
Jan 2016 | - | $35.20 K(-67.1%) |
Date | Annual | Quarterly |
---|---|---|
Oct 2015 | - | $107.10 K(-66.1%) |
July 2015 | $315.50 K(+57.3%) | $315.50 K(+315.1%) |
Apr 2015 | - | $76.00 K(-2.1%) |
Jan 2015 | - | $77.60 K(+8.2%) |
Oct 2014 | - | $71.70 K(-64.3%) |
July 2014 | $200.60 K(+391.7%) | $200.60 K(+950.3%) |
Apr 2014 | - | $19.10 K(+45.8%) |
Jan 2014 | - | $13.10 K(-46.1%) |
Oct 2013 | - | $24.30 K(-40.4%) |
July 2013 | $40.80 K(-26.5%) | $40.80 K(-43.3%) |
Apr 2013 | - | $71.90 K(+18.8%) |
Jan 2013 | - | $60.50 K(+2.9%) |
Oct 2012 | - | $58.80 K(+5.9%) |
July 2012 | $55.50 K(-46.7%) | $55.50 K(-50.1%) |
Apr 2012 | - | $111.20 K(+166.7%) |
Jan 2012 | - | $41.70 K(+52.2%) |
Oct 2011 | - | $27.40 K(-73.7%) |
July 2011 | $104.10 K(-48.9%) | $104.10 K(0.0%) |
Apr 2011 | - | $104.10 K(-55.5%) |
Jan 2011 | - | $233.90 K(0.0%) |
Oct 2010 | - | $233.90 K(+14.7%) |
July 2010 | $203.90 K(>+9900.0%) | $203.90 K(+142.4%) |
Apr 2010 | - | $84.10 K(-49.2%) |
Jan 2010 | - | $165.40 K(>+9900.0%) |
Oct 2009 | - | $1100.00(>+9900.0%) |
July 2009 | $0.00(-100.0%) | $0.00(-100.0%) |
Oct 2008 | - | $23.90 K(+62.6%) |
July 2008 | $14.70 K(+390.0%) | $14.70 K(+390.0%) |
July 2007 | $3000.00 | $3000.00 |
FAQ
- What is Opiant Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals annual accounts payable year-on-year change?
- What is Opiant Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Opiant Pharmaceuticals?
- What is Opiant Pharmaceuticals quarterly accounts payable year-on-year change?
What is Opiant Pharmaceuticals annual accounts payable?
The current annual accounts payable of OPNT is $3.37 M
What is the all time high annual accounts payable for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high annual accounts payable is $3.37 M
What is Opiant Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, OPNT annual accounts payable has changed by +$403.30 K (+13.60%)
What is Opiant Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of OPNT is $3.11 M
What is the all time high quarterly accounts payable for Opiant Pharmaceuticals?
Opiant Pharmaceuticals all-time high quarterly accounts payable is $5.32 M
What is Opiant Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, OPNT quarterly accounts payable has changed by +$532.20 K (+20.62%)